Literature DB >> 31497186

Blood biomarkers for physical recovery in ischemic stroke: a systematic review.

Yun-Ju Lai1,2, Sandra K Hanneman1, Rebecca L Casarez1, Jing Wang3, Louise D McCullough2.   

Abstract

Stroke is a common cause of physical disability. Biomarkers have been used to predict prognosis in ischemic stroke, but studies linking biomarkers to physical recovery from ischemic stroke have not been systematically evaluated since 2011. The purpose of this paper is to report the findings of a systematic review of the intervening literature to identify potential predictive biomarkers for recovery of physical function following ischemic stroke. The PubMed, Embase, and CINAHL databases were searched for studies reported between January 1, 2011, and September 18, 2018. Search criteria were adult ischemic stroke patients, blood sample collection within 24 ± 6 hrs of stroke onset, and outcome measures, including physical function. Identified from 18 studies and representing four biological classifications, 34 biomarkers were significantly associated with physical recovery after ischemic stroke: (1) immune response (15, 44%); (2) lipids/metabolism (4, 12%); (3) neuronal function (4, 12%); and (4) blood vessel/circulation (11, 32%). Of the predictive biomarkers associated with 1-month recovery, 60% (6 of 10) was classified into blood vessel/circulation; 54% (14 of 26) of the biomarkers associated with 3-6 month physical recovery involved the immune response. Blood biomarkers might provide useful information to improve the prediction of physical outcome after ischemic stroke. The data suggest that biomarkers from four biological classifications may predict physical recovery in patients after ischemic stroke.

Entities:  

Keywords:  Biomarker; ischemic stroke; recovery of function

Year:  2019        PMID: 31497186      PMCID: PMC6731415     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  60 in total

Review 1.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 2.  Blood markers for the prognosis of ischemic stroke: a systematic review.

Authors:  William Whiteley; Wei Li Chong; Anshuman Sengupta; Peter Sandercock
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

Review 3.  Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.

Authors:  Jamie L Banks; Charles A Marotta
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

Review 4.  High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review.

Authors:  Pierre Amarenco; Julien Labreuche; Pierre-Jean Touboul
Journal:  Atherosclerosis       Date:  2007-10-17       Impact factor: 5.162

5.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Authors:  H P Adams; P H Davis; E C Leira; K C Chang; B H Bendixen; W R Clarke; R F Woolson; M D Hansen
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

Review 6.  Fibrin(ogen) in cardiovascular disease: an update.

Authors:  Wolfgang Koenig
Journal:  Thromb Haemost       Date:  2003-04       Impact factor: 5.249

Review 7.  Ca2+ signals and neuronal death in brain ischemia.

Authors:  Daniele Bano; Pierluigi Nicotera
Journal:  Stroke       Date:  2007-02       Impact factor: 7.914

8.  Reporting recommendations for tumor marker prognostic studies (REMARK).

Authors:  Lisa M McShane; Douglas G Altman; Willi Sauerbrei; Sheila E Taube; Massimo Gion; Gary M Clark
Journal:  J Natl Cancer Inst       Date:  2005-08-17       Impact factor: 13.506

9.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

Review 10.  Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies.

Authors:  V I Teichberg; K Cohen-Kashi-Malina; I Cooper; A Zlotnik
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

View more
  5 in total

1.  Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review.

Authors:  Te-An Lee; Shih-Han Wang; Chun-Tse Kuo; Chia-Wei Li; Louise D McCullough; Dhimiter Bello; Yun-Ju Lai
Journal:  Transl Oncol       Date:  2022-05-02       Impact factor: 4.803

Review 2.  Protein Biomarkers in Blood Reflect the Interrelationships Between Stroke Outcome, Inflammation, Coagulation, Adhesion, Senescence and Cancer.

Authors:  Georg Fuellen; Uwe Walter; Larissa Henze; Jan Böhmert; Daniel Palmer; Soyoung Lee; Clemens A Schmitt; Henrik Rudolf; Axel Kowald
Journal:  Cell Mol Neurobiol       Date:  2022-08-11       Impact factor: 4.231

Review 3.  Astragalus Mongholicus: A review of its anti-fibrosis properties.

Authors:  Fengying Gong; Rongmei Qu; Yongchun Li; Ying Lv; Jingxing Dai
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

4.  Predictors of urinary tract infection in acute stroke patients: A cohort study.

Authors:  Ya-Ming Li; Jian-Hua Xu; Yan-Xin Zhao
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

Review 5.  Principles and requirements for stroke recovery science.

Authors:  Clemens J Sommer; Wolf-Rüdiger Schäbitz
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-11       Impact factor: 6.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.